Grünenthal Group

About Grünenthal Group

Grünenthal Group is a global, research-based pharmaceutical company headquartered in the UK, dedicated to improving the lives of patients through innovative pain management solutions. Established in 1886, the company has a rich history of developing and delivering effective therapies that address unmet medical needs.

With a strong focus on research and development, Grünenthal invests significantly in discovering new treatments for various pain conditions, including chronic pain and post-operative pain. The company’s commitment to innovation is reflected in its diverse portfolio of products, which includes both prescription medications and over-the-counter solutions.

Grünenthal operates in multiple countries, collaborating with healthcare professionals and stakeholders to ensure that patients have access to the best possible care. The company’s vision is to be a leader in pain management, striving to enhance the quality of life for patients worldwide.

In addition to its pharmaceutical activities, Grünenthal is also committed to sustainability and corporate social responsibility. The company actively engages in initiatives that promote health education and awareness, aiming to empower patients and communities.

• Core Values: Innovation, Integrity, and Patient-Centricity
• Key Areas of Focus: Pain Management, Research & Development, and Sustainability

Grünenthal’s dedication to excellence is evident in its rigorous quality standards and adherence to regulatory requirements. The company continues to expand its global footprint, driven by a passion for making a meaningful difference in the lives of those affected by pain.